Guardant Health (GH) investors have a new number to think about this week.  Bernstein SocGen Group raised its price target on the cancer-screening company's stock to $200 a share, up from $175.

HHS did not respond to a list of questions about how the secretary plans to revamp the task force. Emily Hilliard, senior HHS ...

A single blood draw added to routine cancer screenings found roughly seven times more cancers than standard tests alone, ...

A regular exam isn't just about screenings. It's your chance to ask your healthcare professional about issues or symptoms ...

The ultra-sensitive test can find hidden signs of pancreatic cancer by looking for a key KRAS genetic mutation missed by ...

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at ...

I’ll always wonder if I should have noticed sooner or done something different. The truth is none of these things screamed ...

I enrolled in Human Longevity's executive health program. My cancer results were reassuring, but my genetic results left me a ...

For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...

Ahead of the British Grand Prix, Alpine joined forces with Jeremy Clarkson's Diddly Squat Farm, taking advantage of the close ...

Ahead of the British Grand Prix, Alpine joined forces with Jeremy Clarkson's Diddly Squat Farm, taking advantage of the close ...

Grail is awaiting an FDA ruling on a cancer screening test, but already more tests are finding their way into medical ...